EPID6670
The Pharmaceutical Industry and Health Professionals
10 Units
Not available in 2014
The course will introduce students to the burgeoning evidence, and vigorous contemporary global debates, about the nature and impacts of interactions between the pharmaceutical industry and health professionals. It will combine multi-media material, real world case studies and scientific evidence, producing a lively and engaging educational experience.
| Objectives | By the end of the course students will have a thorough up-to-date understanding of the many forms of industry-professional interactions, examples of those interactions, the results of studies that have examined the consequences of these interactions for practice, and the global contemporary debates about the nature and extent of these interactions. The course will also provide students with an understanding of recent policy developments relevant to these interactions, as changing regulatory regimes, both self-regulatory and statutory, impact on how they are governed. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Content | The current version of the course content contains the following 10 elements and will be developed into the module format used for other EPID courses. 1. Introduction to the pharmaceutical industry: size, structure, marketing, R&D, importance and influence. 2. Sales representatives and health professionals: evidence about reliability of information, gifts, nature of relationship, academic detailing 3. Medical education and industry sponsorship: CME, scientific conferences, medical meetings , medical education companies 4. Sponsored research and clinical trials: systematic review evidence about sponsored trials, trial registers, publication bias 5. Key Opinion Leaders and industry: Company advisory boards, KOLs-thought leaders , media spokespeople, speakers bureaux 6. Medical journals and advertising: publication of sponsored trials, disclosure, advertising, ghost-writing, fake journals, new journals 7. Disease awareness campaigns : direct-to-consumer advertising, condition branding, disease-mongering, public relations, consumer/advocacy groups 8. Professional Associations and industry : changing sponsorship relationships with industry 9. Policy Developments 1, Disclosure : ACCC and the Medicines Australia disclosure regime, United States Congress Sunshine Act 10. Policy Developments 2, Disentanglement: Universities and new CME policies, hospitals and sales reps, IOM report |
||||||||
| Replacing Course(s) | Not applicable | ||||||||
| Transition | Not applicable | ||||||||
| Industrial Experience | 0 | ||||||||
| Assumed Knowledge | The course will be accessible to post-graduate and undergraduate students. Students will have experience or be undertaking a qualification in a relevant health-related field and will have an understanding of the basic principles of public health. | ||||||||
| Modes of Delivery | Distance Learning : IT Based Distance Learning : Paper Based Flexible Delivery / Student Centred Learning |
||||||||
| Teaching Methods | Case Study
Email Discussion Group Problem Based Learning Field Study Lecture Forums Practical Self Directed Learning Student Projects Tutorial |
||||||||
| Assessment Items |
|
||||||||
| Contact Hours | Tutorial: for 1 hour(s) per Week for Full Term Self Directed Learning: for 2 hour(s) per Week for Full Term Lecture: for 1 hour(s) per Week for Full Term Email Discussion Group: for 1 hour(s) per Week for Full Term Student Projects: for 2 hour(s) per Week for Full Term |